Answers are grounded in this paper and cite their sources.
Sabia parviflora is recognized as a significant medicinal plant in traditional Chinese medicine (TCM) and has been extensively utilized for managing rheumatic disorders, nephritic edema, and goiter. However, the biological activities of polysaccharides derived from S. parviflora remain largely unexplored, particularly with respect to their anti-inflammatory potential. In this study, a heteropolysaccharide (SPP) was extracted from S. parviflora stems using hot water extraction, after which ethanol was added for precipitation; the extraction yield reached 4.16% (w/w). The obtained SPP fraction contained 91.29 ± 0.83% (w/w) total carbohydrates and 3.47 ± 0.12% (w/w) protein. Structural characterization demonstrated that SPP is a heteropolysaccharide built from arabinose, galactose, and glucose with a molar ratio of 0.3874: 0.9606: 14.6028, possessing a molecular weight of 533.170 kDa. In vitro assays showed that SPP exhibited concentration-dependent free radical scavenging effects on ABTS, DPPH, superoxide anion, and hydroxyl radicals. Moreover, SPP reduced inflammatory mediator levels and modulated oxidative stress- related indicators in LPS-activated RAW 264.7 macrophage cells. These observations give preliminary evidence of the in vitro bioactivity of SPP. However, its detailed structure, molecular mechanisms, in vivo efficacy, and the possible influence of residual non-polysaccharide components require further investigations.
No takes yet. Share an insight, caveat, or question.
An et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: